You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / ABIM MOC

Simulation Challenge: Treating Relapsed Follicular Lymphoma

  • Authors: Bruce Cheson, MD, FACP, FAAAS, FASCO; Jonathon B. Cohen, MD, MS
  • CME / ABIM MOC Released: 11/20/2019
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 11/20/2020
Start Activity


Target Audience and Goal Statement

This activity is intended for hematology/oncology specialists, pathologists, and primary care physicians.

The goal of this activity is to provide clinicians who treat patients with relapsed follicular lymphoma with the latest scientific data and guideline-based clinical concepts surrounding patient care, including selecting appropriate therapy and optimizing individualized patient care.

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with:
    • Diagnosing patients with relapsed follicular lymphoma 
    • Differentiating among available therapies for patients with relapsed follicular lymphoma
    • Tailoring therapy for relapsed follicular lymphoma based on patient-specific factors and prior treatment
    • Integrating novel therapies into the treatment plans for patients with relapsed follicular lymphoma


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Bruce Cheson, MD, FACP, FAAAS, FASCO

    Deputy Chief of Hematology-Oncology
    Georgetown University Hospital
    Washington, DC

    Disclosures

    Disclosure: Bruce Cheson, MD, FACP, FAAAS, FASCO, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AbbVie Inc.; Astellas Pharma, Inc.; AstraZeneca Pharmaceuticals LP; Celgene Corporation; TG Therapeutics
    Served as a speaker or a member of a speakers bureau for: Celgene Corporation
    Owns stock, stock options, or bonds from: Symbio

  • Jonathon B. Cohen, MD, MS

    Associate Professor
    Emory University
    Winship Cancer institute
    Atlanta, Georgia

    The opinions expressed are those of Dr Cohen and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Cohen’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.

    Disclosures

    Disclosure: Jonathon B. Cohen, MD, MS, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Gilead Sciences, Inc.; Seattle Genetics
    Received grants for clinical research from: Bioinvent; Bristol-Myers Squibb Company; Genentech, Inc.; LAM; Novartis Pharmaceuticals Corporation; Takeda Pharmaceuticals North America, Inc.; Unum

Editor

  • Donna Topping, PharmD, BCOP

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Donna Topping, PharmD, BCOP, has disclosed the following relevant financial relationships:
    Developed content for IME or CPD activities supported by Merck, Takeda, and Roche Latin America.

CME Reviewer

  • Robert Morris, PharmD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: ViiV Healthcare
    Owns stock, stock options, or bonds from: GlaxoSmithKline

Medscape, LLC staff have disclosed that they have no relevant financial relationships. 

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements


 

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Simulation Challenge: Treating Relapsed Follicular Lymphoma

Authors: Bruce Cheson, MD, FACP, FAAAS, FASCO; Jonathon B. Cohen, MD, MSFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC Released: 11/20/2019

Valid for credit through: 11/20/2020

processing....

ABOUT THIS ACTIVITY
Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface.

Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case.

patient simulation
  • Print